Drug Search Results
More Filters [+]

Cinepazide

Alternative Names: cinepazide
Latest Update: 2024-01-06
Latest Update Note: PubMed Publication

Product Description

Cinepazide is an olefinic compound. It derives from a cinnamic acid.Cinepazide has been used in trials studying the treatment of Ischemic Stroke. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Cinepazide)

Mechanisms of Action: Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Korea

Approved Indications: None

Known Adverse Events: None

Company: Qilu
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cinepazide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Ischemic Stroke

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20231896

N/A

Completed

Ischemic Stroke

2023-07-26

ChiCTR1900023827

N/A

Not yet recruiting

Ischemic Stroke

2019-06-30

CTR20160292

P4

Completed

Ischemic Stroke

2019-02-01

CTR20160417

P4

Completed

Ischemic Stroke

2018-05-31

Recent News Events